Third Annual Summit on Disclosure, Transparency and Aggregate Spend for Drug, Device and Biotech Companies

The Third Annual Summit on Disclosure Transparency and Aggregate Spend for Dug, Device and Biotech Companies will provide expert advice on how to manage the potential fallout from these disclosures as well as on the myriad operational questions that companies are now confronting. In-house experts will offer first-hand advice on a wide array of emerging best practices ranging from project management to building scalability and sustainability. Panels of outside experts and third parties will examine various aggregate spend technology solutions. The Summit will also feature senior regulators from the HHS Office of Inspector General (OIG) and other agencies, as well as former Justice Department attorneys, on how the government is likely to use these data.

WHO SHOULD ATTEND

• Pharmaceutical and Health Care Executives
• Medical Device Executives
• Compliance Officers
• Ethics Officers
• General Counsel and Legal Executives
• Finance Executives
• Information Management and Information Technology Executives
• Medical Affairs Directors
• Food and Drug Law Attorneys
• Privacy Officers
• Auditors
• Pharmaceutical Consultants
• Health Care Regulators and Policy Makers
• Health Services Researchers and Academics